Targeting transcription factors for cancer treatment

M Lambert, S Jambon, S Depauw… - Molecules, 2018 - mdpi.com
Transcription factors are involved in a large number of human diseases such as cancers for
which they account for about 20% of all oncogenes identified so far. For long time, with the …

EMT transcription factors in cancer development re-evaluated: Beyond EMT and MET

S Goossens, N Vandamme, P Van Vlierberghe… - … et Biophysica Acta (BBA …, 2017 - Elsevier
Reactivation of an embryonic epithelial-to-mesenchymal (EMT) program is commonly
accepted as a core component of carcinoma progression. Collectively, EMT and …

Epithelial-to-mesenchymal transition: epigenetic reprogramming driving cellular plasticity

N Skrypek, S Goossens, E De Smedt, N Vandamme… - Trends in Genetics, 2017 - cell.com
Epithelial-to-mesenchymal transition (EMT) is a process in which epithelial cells lose their
junctions and polarity to gain a motile mesenchymal phenotype. EMT is essential during …

A comprehensive review of lysine-specific demethylase 1 and its roles in cancer

A Hosseini, S Minucci - Epigenomics, 2017 - Taylor & Francis
Histone methylation plays a key role in the regulation of chromatin structure, and its
dynamics regulates important cellular processes. The investigation of the role of alterations …

Interplay between cofactors and transcription factors in hematopoiesis and hematological malignancies

Z Wang, P Wang, Y Li, H Peng, Y Zhu… - … and Targeted Therapy, 2021 - nature.com
Hematopoiesis requires finely tuned regulation of gene expression at each stage of
development. The regulation of gene transcription involves not only individual transcription …

The crucial role of ZEB2: from development to epithelial‐to‐mesenchymal transition and cancer complexity

M Fardi, M Alivand, B Baradaran… - Journal of cellular …, 2019 - Wiley Online Library
Zinc finger E‐box binding homeobox 2 (ZEB2) is a DNA‐binding transcription factor, which
is mainly involved in epithelial‐to‐mesenchymal transition (EMT). EMT is a conserved …

An" unexpected" role for EMT transcription factors in hematological development and malignancy

K Radhakrishnan, L Truong… - Frontiers in Immunology, 2023 - frontiersin.org
The epithelial to mesenchymal transition (EMT) is a fundamental developmental process
essential for normal embryonic development. It is also important during various pathogenic …

JAK/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALL

A Benyoucef, K Haigh, A Cuddihy, JJ Haigh - Leukemia, 2022 - nature.com
Abstract ETP-ALL (Early T cell Progenitor Acute Lymphoblastic Leukemia) represents a high-
risk subtype of T cell acute lymphocytic leukemia (T-ALL). Therapeutically, ETP-ALL patients …

Intrinsic balance between ZEB family members is important for melanocyte homeostasis and melanoma progression

K Bruneel, J Verstappe, N Vandamme, G Berx - Cancers, 2020 - mdpi.com
It has become clear that cellular plasticity is a main driver of cancer therapy resistance.
Consequently, there is a need to mechanistically identify the factors driving this process. The …

Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition

AK Abdel-Aziz, I Pallavicini, E Ceccacci… - …, 2019 - pmc.ncbi.nlm.nih.gov
Lysine specific demethylase-1 (LSD1) has been shown to be critical in acute myeloid
leukemia (AML) pathogenesis and this has led to the development of LSD1 inhibitors …